US Broker Ratings

Cardinal Health, Inc. (CAH) Stock Analysis: Exploring a 15% Upside Potential in Medical Distribution

Cardinal Health, Inc. (NYSE: CAH) stands as a titan in the healthcare sector, specifically within the medical distribution industry. With a market capitalization of $37.23 billion, this Ohio-based company extends..

Incyte Corporation (INCY) Stock Analysis: Exploring Growth Potential with a 5.66% Upside

Incyte Corporation (NASDAQ: INCY), a prominent player in the biotechnology industry, presents an intriguing opportunity for investors seeking exposure to the healthcare sector. With a market capitalization of $14.76 billion,..

Agilent Technologies (A) Stock Analysis: Exploring a 20.66% Potential Upside and Strong Buy Ratings

Agilent Technologies, Inc. (NYSE: A), a prominent player in the healthcare sector, stands out in the diagnostics and research industry with a market capitalization of $32.24 billion. Headquartered in Santa..

Abbott Laboratories (ABT) Stock Analysis: Exploring a Promising 11.94% Potential Upside

Abbott Laboratories (NYSE: ABT), a stalwart in the healthcare sector, continues to captivate investor interest with its robust market presence and innovative product offerings. Headquartered in North Chicago, Illinois, Abbott..

IQVIA Holdings, Inc. (IQV) Stock Analysis: Healthcare Giant with a 16.77% Potential Upside

IQVIA Holdings, Inc. (NYSE: IQV), a leader in the healthcare sector with a strong focus on diagnostics and research, presents an intriguing opportunity for investors looking to capitalize on its..

IDEXX Laboratories, Inc. (IDXX) Stock Analysis: Unlocking Growth in the Diagnostics & Research Sector

IDEXX Laboratories, Inc. (NASDAQ: IDXX) has established itself as a formidable player in the healthcare sector, particularly within the diagnostics and research industry. With a market capitalization of $43.07 billion,..

ResMed Inc. (RMD) Stock Analysis: A Healthcare Leader’s 25.86% ROE Signals Robust Growth Potential

ResMed Inc. (NYSE: RMD), a stalwart in the healthcare sector, stands out in the medical instruments and supplies industry with an impressive market capitalization of $40.94 billion. Headquartered in San..

Novo Nordisk A/S (NVO) Investor Outlook: Massive 52.57% Potential Upside Amid Robust Revenue Growth

Investors eyeing the pharmaceutical sector should take a closer look at Novo Nordisk A/S (NYSE: NVO), a Denmark-based titan in the healthcare industry, with a market capitalization of $209.97 billion...

Edwards Lifesciences Corporation (EW) Stock Analysis: A 9.56% Potential Upside Amidst Strong Revenue Growth

Edwards Lifesciences Corporation (NYSE: EW), a prominent player in the healthcare sector, specifically within the medical devices industry, has long been at the forefront of innovations in cardiovascular treatments. With..

Alcon Inc. (ALC) Stock Analysis: A 20% Upside Potential in the Healthcare Sector

Alcon Inc. (ALC), a stalwart in the healthcare sector, particularly in medical instruments and supplies, has been catching the attention of investors with its solid market presence and promising future..

BioNTech SE (BNTX) Stock Analysis: A Biotech Titan with 27% Potential Upside

BioNTech SE (NASDAQ: BNTX), a prominent player in the biotechnology sector, has been making waves in the healthcare industry with its innovative approach to developing immunotherapies for cancer and infectious..

Alnylam Pharmaceuticals (ALNY) Stock Analysis: High Growth Potential Amidst Expanding RNAi Pipeline

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY), a leader in the biotechnology sector, has been at the forefront of discovering and commercializing therapeutics based on ribonucleic acid interference (RNAi). With a market..

BeOne Medicines Ltd. (ONC) Investor Outlook: 12.51% Potential Upside Amid Robust Revenue Growth

BeOne Medicines Ltd. (ONC), a prominent player in the biotechnology sector, is making waves with its focus on oncology treatments. Headquartered in Basel, Switzerland, the company is renowned for its..

Thermo Fisher Scientific (TMO) Stock Analysis: Navigating a 19% Potential Upside Amidst Strong Buy Ratings

Thermo Fisher Scientific Inc. (NYSE: TMO), a heavyweight in the healthcare sector, continues to capture investor interest with its robust market presence and strategic developments. With a current market capitalization..

Elevance Health, Inc. (ELV) Stock Analysis: A Strategic Look at its 35.56% Potential Upside

Elevance Health, Inc. (NYSE: ELV), a prominent player in the healthcare plans sector, is capturing investor attention with a considerable potential upside of 35.56%. As healthcare remains a crucial focus..

CVS Health Corporation (CVS) Stock Analysis: A 27.91% Upside Potential Amid Strong Buy Ratings

Investors looking for stability and growth in the healthcare sector might find CVS Health Corporation (NYSE: CVS) a promising option. With a market capitalization of $79.23 billion, CVS is a..

Centene Corporation (CNC) Stock Analysis: Exploring a 37.50% Potential Upside in the Healthcare Sector

Centene Corporation (NYSE: CNC) stands as a formidable player in the U.S. healthcare sector, specializing in healthcare plans and services that cater to under-insured and uninsured families, as well as..

GE HealthCare Technologies Inc. (GEHC) Stock Analysis: Navigating a 26% Potential Upside in the Healthcare Sector

For investors eyeing opportunities in the healthcare sector, GE HealthCare Technologies Inc. (NYSE: GEHC) presents a compelling narrative. With a market capitalization of $31.89 billion, this Chicago-based company stands strong..

Johnson & Johnson (JNJ) Stock Analysis: Evaluating a 4.54% Growth Potential in the Healthcare Giant

Johnson & Johnson (NYSE: JNJ), a stalwart in the healthcare sector, continues to capture the interest of investors with its robust market presence and potential for growth. With a market..

HCA Healthcare, Inc. (HCA) Stock Analysis: Exploring a 10.27% Upside Potential and Robust Growth Metrics

As one of the leading entities in the U.S. medical care facilities industry, HCA Healthcare, Inc. (NYSE: HCA) presents a compelling investment opportunity. With a market capitalization of $85.88 billion,..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds